Agilent is reportedly seeking a buyer for its semiconductor business, a move that would allow it to shed a laggard among its divisions and focus on its more profitable test and measurement group and life sciences and chemical analysis business.

According to the Wall Street Journal, the firm has hired investment bank Goldman Sachs Group to find a buyer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.